N

Neurocrine Biosciences
D

NBIX

135.460
USD
0.49
(0.36%)
Market Closed
Volume
56,839
EPS
5
Div Yield
-
P/E
36
Market Cap
13,714,906,564
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    A
    ALKS
    -0.220
    (-0.73%)
    29.750 USD
    A
    AVDL
    0.175
    (1.73%)
    10.305 USD
    E
    ESPR
    0.00000
    (0.00%)
    2.18000 USD
    I
    INSM
    1.080
    (1.56%)
    70.440 USD
    S
    SAGE
    0.60500
    (12.09%)
    5.61000 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    TEVA
    TEVA
    0.775
    (3.64%)
    22.090 USD
    More
News

Title: Neurocrine Biosciences

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.